These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 16898609

  • 1. [The gastrointestinal motor function in irritable bowel syndrome (IBS)].
    Sagami Y, Hongo M.
    Nihon Rinsho; 2006 Aug; 64(8):1441-5. PubMed ID: 16898609
    [Abstract] [Full Text] [Related]

  • 2. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M, Hongo M, Fukudo S.
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [Abstract] [Full Text] [Related]

  • 3. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
    Fukudo S.
    J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026
    [Abstract] [Full Text] [Related]

  • 4. [Brain-gut interactions in irritable bowel syndrome: physiological and psychological aspect].
    Fukudo S, Muranaka M, Nomura T, Satake M.
    Nihon Rinsho; 1992 Nov; 50(11):2703-11. PubMed ID: 1337564
    [Abstract] [Full Text] [Related]

  • 5. Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome.
    Kano M, Muratsubaki T, Van Oudenhove L, Morishita J, Yoshizawa M, Kohno K, Yagihashi M, Tanaka Y, Mugikura S, Dupont P, Ly HG, Takase K, Kanazawa M, Fukudo S.
    Sci Rep; 2017 Sep 29; 7(1):12425. PubMed ID: 28963545
    [Abstract] [Full Text] [Related]

  • 6. Alterations of sensori-motor functions of the digestive tract in the pathophysiology of irritable bowel syndrome.
    Delvaux M.
    Best Pract Res Clin Gastroenterol; 2004 Aug 29; 18(4):747-71. PubMed ID: 15324712
    [Abstract] [Full Text] [Related]

  • 7. [Pathophysiology of irritable bowel syndrome].
    Torii A.
    Nihon Rinsho; 2006 Aug 29; 64(8):1452-5. PubMed ID: 16898611
    [Abstract] [Full Text] [Related]

  • 8. Significance of increased human colonic permeability in response to corticotrophin-releasing hormone (CRH).
    Ferrier L.
    Gut; 2008 Jan 29; 57(1):7-9. PubMed ID: 18094198
    [No Abstract] [Full Text] [Related]

  • 9. Changes in brain G proteins and colonic sympathetic neural signaling in chronic-acute combined stress rat model of irritable bowel syndrome (IBS).
    Zou N, Lv H, Li J, Yang N, Xue H, Zhu J, Qian J.
    Transl Res; 2008 Dec 29; 152(6):283-9. PubMed ID: 19059163
    [Abstract] [Full Text] [Related]

  • 10. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.
    Nozu T, Okumura T.
    J Gastroenterol; 2015 Aug 29; 50(8):819-30. PubMed ID: 25962711
    [Abstract] [Full Text] [Related]

  • 11. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome.
    Sagami Y, Shimada Y, Tayama J, Nomura T, Satake M, Endo Y, Shoji T, Karahashi K, Hongo M, Fukudo S.
    Gut; 2004 Jul 29; 53(7):958-64. PubMed ID: 15194643
    [Abstract] [Full Text] [Related]

  • 12. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome.
    Fukudo S, Nomura T, Hongo M.
    Gut; 1998 Jun 29; 42(6):845-9. PubMed ID: 9691924
    [Abstract] [Full Text] [Related]

  • 13. [The pathophysiology of irritable bowel syndrome].
    Zouiten ML, Karoui S, Boubaker J, Fekih M, Mechmeche R, Filali A.
    Tunis Med; 2006 May 29; 84(5):269-74. PubMed ID: 16915774
    [Abstract] [Full Text] [Related]

  • 14. Peripheral factors in the pathophysiology of irritable bowel syndrome.
    Gunnarsson J, Simrén M.
    Dig Liver Dis; 2009 Nov 29; 41(11):788-93. PubMed ID: 19665956
    [Abstract] [Full Text] [Related]

  • 15. Motility disorders in the irritable bowel syndrome.
    Lind CD.
    Gastroenterol Clin North Am; 1991 Jun 29; 20(2):279-95. PubMed ID: 2066153
    [Abstract] [Full Text] [Related]

  • 16. Recto-colonic reflex is impaired in patients with irritable bowel syndrome.
    van der Veek PP, Steenvoorden M, Steens J, van der Schaar PJ, Brussee J, Masclee AA.
    Neurogastroenterol Motil; 2007 Aug 29; 19(8):653-9. PubMed ID: 17640180
    [Abstract] [Full Text] [Related]

  • 17. Differential Activation in Amygdala and Plasma Noradrenaline during Colorectal Distention by Administration of Corticotropin-Releasing Hormone between Healthy Individuals and Patients with Irritable Bowel Syndrome.
    Tanaka Y, Kanazawa M, Kano M, Morishita J, Hamaguchi T, Van Oudenhove L, Ly HG, Dupont P, Tack J, Yamaguchi T, Yanai K, Tashiro M, Fukudo S.
    PLoS One; 2016 Aug 29; 11(7):e0157347. PubMed ID: 27448273
    [Abstract] [Full Text] [Related]

  • 18. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC, Brzozowski T, Konturek SJ.
    J Physiol Pharmacol; 2011 Dec 29; 62(6):591-9. PubMed ID: 22314561
    [Abstract] [Full Text] [Related]

  • 19. Effect of alpha-helical CRH on quantitative electroencephalogram in patients with irritable bowel syndrome.
    Tayama J, Sagami Y, Shimada Y, Hongo M, Fukudo S.
    Neurogastroenterol Motil; 2007 Jun 29; 19(6):471-83. PubMed ID: 17564629
    [Abstract] [Full Text] [Related]

  • 20. Disturbances of motility and visceral hypersensitivity in irritable bowel syndrome: biological markers or epiphenomenon.
    Quigley EM.
    Gastroenterol Clin North Am; 2005 Jun 29; 34(2):221-33, vi. PubMed ID: 15862931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.